A dubious pharmaceutical startup recently bought the rights to a drug that treats a parasitic infection, then raised the price 500-fold seemingly over night. The drug targets a somewhat rare condition that affects immune compromised pregnant women, but also malaria and AIDS. Ironically enough, it was developed by a much hated big pharma company, GlaxoSmithKline, in 1953 and used to cost $1 a pill only a couple years ago. It has since traded hands twice, before coming under the control of Turing Pharmaceuticals, a start-up run by a former hedge fund manager.
Popular weight loss aid Alli has been available since 2009; you take it three times a week for 12 weeks, and if everything goes according to plan, you lose 10 percent of your body fat. Over 12 million people worldwide use it, because, as it turns out, it’s actually quite good. But according to a study recently published in Biochemical
No less than 1 million birth control pills have been taken from the shelves by big pharma Pfizer in the United States because they might not contain enough contraceptive to prevent pregnancy. Whoa! Wait just a moment there. They might not have enough contraceptive? As in, if I took the pills, I might get pregnant? Not quite what many women